Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
Phase 2 Terminated
15 enrolled 10 charts
PER2PSMA
Completed
70 enrolled
HPGD-ccRCC
Completed
40 enrolled
ENPP1-BC
Completed
12 enrolled
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
Diagnostic Study of Patients With Stage I Testicular Cancer
Phase NA Completed
76 enrolled
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
Phase 1/2 Terminated
26 enrolled 11 charts
Brivanib Metastatic Renal Cell Carcinoma
Phase 2 Terminated
10 enrolled
Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
Completed
43 enrolled
Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer
Phase 2 Terminated
19 enrolled 11 charts
Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma
Phase NA Unknown
80 enrolled
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
Phase 1 Terminated
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
Completed
155 enrolled
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
Phase 2 Completed
5 enrolled 6 charts
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803
Completed
37 enrolled
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Completed
25 enrolled
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Completed
20 enrolled
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
Completed
98 enrolled
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
Phase 1 Terminated
17 enrolled
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
Withdrawn
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
Phase 1 Completed
50 enrolled
GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer
Phase 1 Completed
24 enrolled
Proteases in Patients With Prostate Cancer That Has Spread to the Bone
Completed
31 enrolled
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
Phase 3 Unknown
3,400 enrolled
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Phase 2 Unknown
20 enrolled
DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE
Completed
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer
Phase 2 Unknown
41 enrolled
Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery
Phase 2 Completed
17 enrolled 9 charts
Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery
Phase 2 Terminated
5 enrolled
Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer
Phase 1 Terminated
8 enrolled
Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant
Phase 1 Completed
49 enrolled
Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Phase 2 Terminated
40 enrolled
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
Phase 2 Terminated
100 enrolled